Investors & Media International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease International Stem Cell Corporation Announces Operating Results for the Three and Six-Months ended June 30, 2017 International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017 International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson's Disease International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson's Disease at the ASGCT 2017 Annual Meeting International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial International Stem Cell Corporation Announces 2016 Fourth Quarter and Year-End Results 1 2 3 4 5 6 7 8 9 10 << < > >>
